- Home
- ALT vs CHCT Comparison
ALT vs CHCT Comparison
Compare ALT & CHCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | CHCT |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 415.3M | 493.1M |
| IPO Year | 2005 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ALT | CHCT |
|---|---|---|
| Price | $3.50 | $16.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $15.50 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 2.9M | 370.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.82% |
| EPS Growth | 25.37 | ★ 134.78 |
| EPS | N/A | ★ 0.08 |
| Revenue | $41,000.00 | ★ $121,195,000.00 |
| Revenue This Year | N/A | $9.06 |
| Revenue Next Year | $756,308.50 | $8.61 |
| P/E Ratio | ★ N/A | $202.00 |
| Revenue Growth | ★ 105.00 | 4.67 |
| 52 Week Low | $2.91 | $13.23 |
| 52 Week High | $7.73 | $18.90 |
Technical Indicators
Market Signals| Indicator | ALT | CHCT |
|---|---|---|
| Relative Strength Index (RSI) | 33.42 | 34.61 |
| Support Level | $3.40 | $14.96 |
| Resistance Level | $4.25 | $17.34 |
| Average True Range (ATR) | 0.24 | 0.43 |
| MACD | -0.06 | -0.12 |
| Stochastic Oscillator | 7.07 | 9.15 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About CHCT Community Healthcare Trust Incorporated
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems, or other healthcare service providers in non-urban markets. The company derives the majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.